The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II trial of LAVA-1207, a novel bispecific gamma-delta T-cell engager alone, or with low dose IL-2 or pembrolizumab, in metastatic castration resistant prostate cancer (mCRPC).
 
Niven Mehra
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; MSD Oncology (Inst); Pfizer
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca/Merck (Inst); Bristol Myers Squibb Foundation (Inst); Janssen-Cilag (Inst)
 
Jens Voortman
Consulting or Advisory Role - Janssen (Inst)
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
David R Wise
Stock and Other Ownership Interests - Doximity
Honoraria - OncLive
Consulting or Advisory Role - Accutar Biotech; Alphasights; AstraZeneca; Bayer; Gerson Lehrman Group; Guidepoint Global; Leap Therapeutics; Lilly; Myovant Sciences; Pfizer; Sanofi; silverlight
Travel, Accommodations, Expenses - Pfizer
 
Emiliano Calvo
Employment - HM Hospitales; START
Leadership - BeiGene; European Organisation for Research and Treatment of Cancer (EORTC); Merus NV; Novartis; PharmaMar; Sanofi; START
Stock and Other Ownership Interests - Oncoart Associated; START
Honoraria - HM Hospitales
Consulting or Advisory Role - Adcendo; Amunix; Anaveon; AstraZeneca/MedImmune; Bristol-Myers Squibb; Chugai Pharma; Diaccurate; Elevation Oncology; Ellipses Pharma; Genmab; Janssen-Cilag; MonTa Biosciences; MSD Oncology; Nanobiotix; Nouscom; Novartis; OncoDNA; PharmaMar; Roche/Genentech; Servier; Syneos Health; T-Knife; TargImmune Therapeutics
Research Funding - START
Other Relationship - CRIS Cancer Foundation; Foundation PharmaMar; Investigational Therapeutics in Oncological Sciences
 
Josep M. Piulats
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Clovis Oncology; IDEAYA Biosciences; Immunocore; Janssen Oncology; Merck Sharp & Dohme; Pfizer; Roche/Genentech; VCN Biosciences
Research Funding - AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Immunocore; Incyte; Janssen Oncology; Merck Sharp & Dohme; Mirati Therapeutics; Pfizer/EMD Serono
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Janssen Oncology; Pfizer; Roche
 
Enrique Gonzalez-Billalabeitia
Consulting or Advisory Role - AstraZeneca; Bayer; Janssen Oncology
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Pfizer; Roche; Sanofi
 
Ignacio Ortego
Consulting or Advisory Role - AstraZeneca
 
Umang Swami
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Exelixis; Gilead Sciences; Imvax; Pfizer; Sanofi; Seagen
Research Funding - Exelixis (Inst); Janssen (Inst); Seattle Genetics/Astellas (Inst)
 
Joel Picus
Research Funding - lava therapeutics (Inst); Merck (Inst); Novartis (Inst); Seagen (Inst)
 
Meghan Karlik
Employment - Lava Therapeutics
 
Teeru Bihani
Employment - Lava Therapeutics
 
Jurjen Ruben
Employment - Lava Therapeutics
 
Sonia Macia
Employment - Highlight Therapeutics; lava therapeutics
Stock and Other Ownership Interests - lava therapeutics
 
Hans J. van der Vliet
Employment - Lava Therapeutics
 
Marya F. Chaney
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Debbie Robbrecht
Honoraria - Springer
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Axiom Healthcare Strategies; BMS; Janssen (Inst); MSD Oncology (Inst); Pfizer (Inst); Pfizer (Inst)
Research Funding - Merck KGaA (Inst)
Travel, Accommodations, Expenses - Janssen